Altice USA, Inc. (ATUS) Reaches $17.70 After 9.00% Down Move; Healthcor Management LP Has Trimmed By $146.47 Million Its Medtronic Plc (MDT) Holding

June 12, 2018 - By Ellis Scott

Medtronic plc (NYSE:MDT) Logo

The stock of Altice USA, Inc. (NYSE:ATUS) is a huge mover today! The stock decreased 1.12% or $0.2 during the last trading session, reaching $17.7. About 4.75M shares traded or 49.78% up from the average. Altice USA, Inc. (NYSE:ATUS) has 0.00% since June 12, 2017 and is . It has underperformed by 12.57% the S&P500. Some Historical ATUS News: ; 12/03/2018 – ALTICE NV ATCA.AS – ALTICE ENTERS INTO EXCLUSIVITY FOR SALE OF ITS INTERNATIONAL WHOLESALE VOICE CARRIER BUSINESS; 17/05/2018 – Altice Europe 1Q Adjusted Ebitda EUR1.26B; 09/05/2018 – Altice USA revenue rises on Suddenlink additions, higher ad revenue; 08/03/2018 GILAT: ALTICE PORTUGAL PICKS GILAT FOR SATELLITE BACKHAULING; 14/05/2018 – ALTICE USA DECLARES ONE-TIME CASH DIV OF $2.035/SHR; 24/04/2018 – NatureWorks Names Richard Altice New President and CEO; 12/03/2018 – Altice enters into agreement for sale of international voice carrier unit; 12/03/2018 – TOFANE GLOBAL IN EXCLUSIVE TALKS TO BUY ALTICE INTL WHOLESALE; 15/03/2018 – Altice NV 4Q Adjusted EBITDA Margin 41%; 09/05/2018 – ALTICE USA SAYS WILL UPGRADE TO IP VIDEO DELIVERY, WHICH IS “OPTIMAL FOR UNICAST AND MULTICAST VIDEO” – CONF CALLThe move comes after 7 months negative chart setup for the $13.05B company. It was reported on Jun, 12 by Barchart.com. We have $16.11 PT which if reached, will make NYSE:ATUS worth $1.17 billion less.




Healthcor Management Lp decreased Medtronic Plc (MDT) stake by 93.89% reported in 2018Q1 SEC filing. Healthcor Management Lp sold 1.83M shares as Medtronic Plc (MDT)’s stock rose 4.71%. The Healthcor Management Lp holds 119,120 shares with $9.56 million value, down from 1.95 million last quarter. Medtronic Plc now has $117.41B valuation. The stock increased 0.13% or $0.11 during the last trading session, reaching $86.7. About 1.75 million shares traded. Medtronic plc (NYSE:MDT) has risen 0.84% since June 12, 2017 and is uptrending. It has underperformed by 11.73% the S&P500. Some Historical MDT News: ; 24/05/2018 – Medtronic PLC 4Q Net $1.46B; 24/05/2018 – MEDTRONIC 4Q ADJ EPS $1.42, EST. $1.38; 17/04/2018 – Medtronic Expands Focus on lnterventional Oncology with Its U.S. Launch of OptiSphere(TM) Embolization Spheres; 24/05/2018 – Medtronic 4Q Restorative Therapies Rev $2.13B, Up 9%; 07/05/2018 – Mike Weinstein to Join Medtronic as Senior Vice President of Strategy; 11/04/2018 – Pioneer Funds – Global Select Exits Medtronic; 11/05/2018 – Medtronic: 7 Adverse Effects Reported in 6 of 79 Studied Patients; 08/03/2018 – Medtronic EVP & CVG President Mike Coyle to Speak at Cowen Healthcare Conference; 19/04/2018 – FBO:Veteran Aff: Veterans Affairs Contract Award – 65– External Pace maker Medtronic Md 5293 (VA-18-00054293) – 36C24718Q0468; 25/05/2018 – MEDTRONIC PLC MDT.N : MORGAN STANLEY RAISES TARGET PRICE TO $95 FROM $90

Analysts await Medtronic plc (NYSE:MDT) to report earnings on August, 28. They expect $1.13 earnings per share, up 0.89% or $0.01 from last year’s $1.12 per share. MDT’s profit will be $1.53B for 19.18 P/E if the $1.13 EPS becomes a reality. After $1.42 actual earnings per share reported by Medtronic plc for the previous quarter, Wall Street now forecasts -20.42% negative EPS growth.

More notable recent Medtronic plc (NYSE:MDT) news were published by: Nasdaq.com which released: “Boston Scientific Corporation Stock Surges on Potential Stryker Takeover” on June 11, 2018, also Seekingalpha.com with their article: “Medtronic Should Focus On Aggressive Deleveraging” published on May 15, 2018, Seekingalpha.com published: “Medtronic slips 1% after Analyst Day” on June 05, 2018. More interesting news about Medtronic plc (NYSE:MDT) were released by: Seekingalpha.com and their article: “Medtronic plc 2018 Q4 – Results – Earnings Call Slides” published on May 24, 2018 as well as Globenewswire.com‘s news article titled: “Medtronic to Participate in Goldman Sachs Global Healthcare Conference” with publication date: May 29, 2018.

Investors sentiment increased to 1.08 in 2018 Q1. Its up 0.06, from 1.02 in 2017Q4. It is positive, as 80 investors sold MDT shares while 383 reduced holdings. 88 funds opened positions while 414 raised stakes. 1.04 billion shares or 0.00% more from 1.04 billion shares in 2017Q4 were reported. Amica Pension Fund Board Of Trustees stated it has 58,793 shares. Hbk Sorce Advisory Ltd Liability Corporation owns 5,013 shares or 0.05% of their US portfolio. Fiduciary has invested 0.23% of its portfolio in Medtronic plc (NYSE:MDT). Voya Invest Mgmt Lc reported 775,074 shares. Stratos Wealth Prtn invested 0.06% in Medtronic plc (NYSE:MDT). Quadrant Mngmt Ltd Liability accumulated 1.97% or 33,450 shares. Private Harbour Investment Mgmt Counsel Lc holds 2.29% or 30,360 shares. Parthenon Ltd Llc has invested 1.67% in Medtronic plc (NYSE:MDT). Manchester Capital Lc holds 0% in Medtronic plc (NYSE:MDT) or 207 shares. Thrivent Fincl For Lutherans holds 1.85M shares. Gabelli Funds Lc owns 112,500 shares or 0.05% of their US portfolio. 150 were accumulated by Rech Management. Fayez Sarofim And accumulated 0.03% or 65,962 shares. Dixon Hubard Feinour And Brown Va accumulated 3,000 shares. Amundi Pioneer Asset Mgmt stated it has 0.53% of its portfolio in Medtronic plc (NYSE:MDT).

Healthcor Management Lp increased Boston Scientific Corp (NYSE:BSX) stake by 205,648 shares to 573,480 valued at $15.67 million in 2018Q1. It also upped Regeneron Pharmaceuticals (NASDAQ:REGN) stake by 300,000 shares and now owns 625,000 shares. Livanova Plc was raised too.

Among 30 analysts covering Medtronic (NYSE:MDT), 19 have Buy rating, 0 Sell and 11 Hold. Therefore 63% are positive. Medtronic had 89 analyst reports since August 10, 2015 according to SRatingsIntel. The stock has “Buy” rating by Deutsche Bank on Thursday, June 2. On Wednesday, June 1 the stock rating was downgraded by BTIG Research to “Neutral”. The rating was maintained by Northland Capital on Friday, April 21 with “Hold”. The rating was maintained by Jefferies with “Hold” on Friday, September 4. The rating was maintained by BTIG Research with “Hold” on Thursday, May 25. UBS maintained it with “Buy” rating and $94 target in Friday, February 17 report. The stock of Medtronic plc (NYSE:MDT) earned “Outperform” rating by Credit Suisse on Monday, August 10. The firm has “Buy” rating by Needham given on Tuesday, September 5. The firm earned “Equal-Weight” rating on Monday, February 5 by Morgan Stanley. On Monday, June 26 the stock rating was maintained by Oppenheimer with “Buy”.

Analysts await Altice USA, Inc. (NYSE:ATUS) to report earnings on July, 26. They expect $-0.04 earnings per share, up 76.47% or $0.13 from last year’s $-0.17 per share. After $-0.16 actual earnings per share reported by Altice USA, Inc. for the previous quarter, Wall Street now forecasts -75.00% EPS growth.

Cablevision Systems Corporation, through its wholly-owned subsidiary CSC Holdings, LLC, owns and operates cable systems and owns companies that provide regional news, local programming, and advertising sales services for the cable television industry and Ethernet data, Internet, voice and video transport, and managed services to the business market. The company has market cap of $13.05 billion. The firm was founded in 1997 and is based in Bethpage, New York. It has a 8.12 P/E ratio.

Among 6 analysts covering Altice USA (NYSE:ATUS), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Altice USA had 7 analyst reports since June 23, 2017 according to SRatingsIntel. Wells Fargo initiated Altice USA, Inc. (NYSE:ATUS) rating on Wednesday, July 26. Wells Fargo has “Market Perform” rating and $34 target. As per Friday, September 15, the company rating was downgraded by Guggenheim. The firm earned “Buy” rating on Friday, November 10 by Moffett Nathanson. The rating was maintained by Pivotal Research on Wednesday, December 6 with “Buy”. Goldman Sachs upgraded the shares of ATUS in report on Tuesday, November 7 to “Buy” rating. As per Friday, June 23, the company rating was initiated by Pivotal Research. The rating was maintained by RBC Capital Markets on Tuesday, November 14 with “Outperform”.

Altice USA, Inc. (NYSE:ATUS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.